Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.

Cancer Med · 2016 · PMC5055166 · PMID 27457217

Europe PMC DOI

hedged sentence

0.1010

closest p · 2.0× alpha

0.1010

boldest claim

The sentences

did not reach statistical significanceP = 0.101not close (p > 0.1)

The subdivision according to ΔHMGB1 showed a similar trend with regard to DFS which, however, did not reach statistical significance (56.2 months vs. 46.6 months for patients with ΔHMGB1 > 1.1 ng/mL or ΔHMGB1 < 1.1 ng/mL, respectively; log rank P = 0.101), which appears to be a numerical issue only because of the limited number of observed events.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.